Heart Failure Risk Reduction in Diabetes: What the Practicing Endocrinologist Should Know

On-demand webinar on leveraging the cardioprotective effects of SGLT2 inhibitors to reduce heart failure risk in your patients with type 2 diabetes.
Jennifer B. Green, MD
Mikhail N. Kosiborod, MD
Released: June 21, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings